Alvotech (NASDAQ:ALVOW – Get Free Report) is expected to announce its results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of ($0.0008) per share and revenue of $165.9450 million for the quarter.
Alvotech Price Performance
Shares of ALVOW opened at $0.33 on Wednesday. The company’s 50 day moving average price is $0.45 and its 200 day moving average price is $0.87. Alvotech has a 52 week low of $0.15 and a 52 week high of $3.00.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Further Reading
- Five stocks we like better than Alvotech
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
